MacaquesBetween Humans and Rhesus Conserved MHC Class I Peptide Binding
暂无分享,去创建一个
John Sidney | Alessandro Sette | David I. Watkins | John L. Dzuris | Ettore Appella | J. Sidney | A. Sette | D. Watkins | E. Appella | J. Dzuris
[1] K. Parker,et al. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs. , 1993, Journal of immunology.
[2] J. Sidney,et al. Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism , 1999, Immunogenetics.
[3] A Sette,et al. Human class I supertypes and CTL repertoires extend to chimpanzees. , 1998, Journal of immunology.
[4] P Parham,et al. Analysis of a successful immune response against hepatitis C virus. , 1999, Immunity.
[5] N. Suciu-Foca,et al. Naturally processed HLA class I bound peptides from c-myc-transfected cells reveal allele-specific motifs. , 1993, Journal of immunology.
[6] G. Brownlee,et al. Characterization of two distinct major histocompatibility complex class I Kk-restricted T-cell epitopes within the influenza A/PR/8/34 virus hemagglutinin , 1991, Journal of virology.
[7] A. Hughes,et al. Definition of an epitope and MHC class I molecule recognized by gag-specific cytotoxic T lymphocytes in SIVmac-infected rhesus monkeys. , 1991, Journal of immunology.
[8] P. Coulie,et al. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas , 1993, The Journal of experimental medicine.
[9] V. Gnau,et al. Dominant aromatic/aliphatic C-terminal anchor in HLA-B*2702 and B*2705 peptide motifs , 2004, Immunogenetics.
[10] D. R. Madden,et al. The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation , 1991, Nature.
[11] A. Vitiello,et al. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. , 1994, Journal of immunology.
[12] H. Rammensee,et al. Comparison of the H-2Kk- and H-2Kkm1-restricted peptide motifs. , 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.
[13] D. R. Madden,et al. Identification of self peptides bound to purified HLA-B27 , 1991, Nature.
[14] D. Ho,et al. Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry , 1997, Journal of virology.
[15] R. Hunter,et al. Use of the rhesus monkey as an experimental model to test the degree of efficacy of an anti-sporozoite peptide malaria vaccine candidate combined with copolymer-based adjuvants. , 1995, The American journal of tropical medicine and hygiene.
[16] A Sette,et al. Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. , 1996, Immunology today.
[17] A. Hughes,et al. The MHC class I genes of the rhesus monkey. Different evolutionary histories of MHC class I and II genes in primates. , 1996, Journal of immunology.
[18] D. Wiley,et al. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. , 1991, Journal of molecular biology.
[19] William S. Lane,et al. Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle , 1992, Nature.
[20] P. Driscoll,et al. Precise prediction of a Kk-restricted cytotoxic T cell epitope in the NS1 protein of influenza virus using an MHC allele-specific motif. , 1993, Virology.
[21] M. Shapiro,et al. Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge. , 1997, Vaccine.
[22] V. Arankalle,et al. Cross‐challenge studies in rhesus monkeys employing different Indian isolates of hepatitis E virus , 1995, Journal of medical virology.
[23] D. Wiley,et al. The antigenic identity of peptide-MHC complexes: A comparison of the conformations of five viral peptides presented by HLA-A2 , 1993, Cell.
[24] V. Gnau,et al. Peptide motifs of HLA-A1,-A11,-A31, and-A33 molecules , 1994, Immunogenetics.
[25] K. Parker,et al. Endogenous peptides bound to HLA-A3 possess a specific combination of anchor residues that permit identification of potential antigenic peptides. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[26] T. Kodama,et al. A helper T‐cell antigen enhances generation of hepatitis C virus‐specific cytotoxic T lymphocytes in vitro , 1995, Journal of medical virology.
[27] E. Padlan,et al. Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex , 1992, The Journal of experimental medicine.
[28] G Hermanson,et al. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. , 1995, Journal of immunology.
[29] M F del Guercio,et al. Several HLA alleles share overlapping peptide specificities. , 1995, Journal of immunology.
[30] E. Murray,et al. The SIV‐infected rhesus monkey model for HIV‐associated dementia and implications for neurological diseases , 1999, Journal of leukocyte biology.
[31] P. Cresswell,et al. Mechanisms of MHC class I--restricted antigen processing. , 1998, Annual review of immunology.
[32] E. Padlan,et al. H-2Dd exploits a four residue peptide binding motif , 1993, The Journal of experimental medicine.
[33] V. Gnau,et al. Peptide motifs of HLA-B58, B60, B61, and B62 molecules , 2004, Immunogenetics.
[34] Didier Rognan,et al. Fine specificity of antigen binding to two class I major histocompatibility proteins (B*2705 and B*2703) differing in a single amino acid residue , 1997, J. Comput. Aided Mol. Des..
[35] C. Bordignon,et al. Characterization of natural peptide ligands for HLA-B*4402 and -B*4403: implications for peptide involvement in allorecognition of a single amino acid change in the HLA-B44 heavy chain. , 1994, Tissue antigens.
[36] S. Zolla-Pazner,et al. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor , 1997, Journal of virology.
[37] Hans-Georg Rammensee,et al. MHC ligands and peptide motifs: first listing , 2004, Immunogenetics.
[38] R. Desrosiers,et al. Comparative biology of natural and experimental SIVmac infection in macaque monkeys: a review. , 1990, Journal of medical primatology.
[39] E. Adams,et al. The Origins of HLA‐A,B,C Polymorphism , 1995, Immunological reviews.
[40] H. Rammensee,et al. Peptide motifs of HLA-B38 and B39 molecules , 2004, Immunogenetics.
[41] H. Rammensee,et al. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.
[42] A. Townsend,et al. Antigen recognition by class I-restricted T lymphocytes. , 1989, Annual review of immunology.
[43] A Sette,et al. Definition of specific peptide motifs for four major HLA-A alleles. , 1994, Journal of immunology.
[44] Todd M. Allen,et al. Characterization of the peptide binding motif of a rhesus MHC class I molecule (Mamu-A*01) that binds an immunodominant CTL epitope from simian immunodeficiency virus. , 1998, Journal of immunology.
[45] R. Desrosiers,et al. Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. , 1985, Science.
[46] D. Nixon,et al. Cytotoxic T lymphocyte epitopes shared between HIV-1, HIV-2, and SIV. , 1993, Journal of medical primatology.
[47] C. Griscelli,et al. Selective tropism of lymphadenopathy associated virus (LAV) for helper-inducer T lymphocytes. , 1984, Science.
[48] Todd M. Allen,et al. Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef , 1999, Nature Medicine.
[49] K. Parker,et al. Endogenous peptides with distinct amino acid anchor residue motifs bind to HLA-A1 and HLA-B8. , 1994, Journal of immunology.
[50] J. Sidney,et al. HLA supertypes and supermotifs: a functional perspective on HLA polymorphism. , 1998, Current opinion in immunology.
[51] B. Johnson,et al. Animal models of Lyme disease: pathogenesis and immunoprophylaxis. , 1994, Trends in microbiology.
[52] K. Parker,et al. The HLA-B14 peptide binding site can accommodate peptides with different combinations of anchor residues. , 1994, The Journal of biological chemistry.
[53] Y. Ito,et al. A nonhuman primate model for human cerebral malaria: rhesus monkeys experimentally infected with Plasmodium fragile. , 1994, Experimental parasitology.
[54] F. Greenwood,et al. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. , 1963, The Biochemical journal.
[55] A. Osterhaus,et al. Towards an HIV-1 vaccine: lessons from studies in macaque models. , 1998, Vaccine.